Literature DB >> 15903250

Recombinant antibody production by perfusion cultures of rCHO cells in a depth filter perfusion system.

Joon Chul Lee1, Ho Nam Chang, Duk Jae Oh.   

Abstract

Recombinant Chinese hamster ovary cells, producing recombinant antibody against the human platelet, were cultivated in a depth filter perfusion system (DFPS). When perfusion cultures with working volume of 1 L were operated at perfusion rates of 5/d and 6/d, volumetric antibody productivities reached values 28 and 34 times higher than that of batch suspension culture in Erlenmeyer flasks and 43 and 53 times higher than that of batch culture in a controlled stirred tank reactor, respectively. Perfusion cultures in the DFPS showed stable antibody production over the whole culture period of up to 20 days. In the DFPS, inoculated cells in suspension were entrapped in a few hours within the depth filter matrix by medium circulation and retained there until the void space of the filter matrix was saturated by the cultured cells. After cells in the depth filter matrix reached saturation, overgrown viable cells at a perfusion rate of 5/d or 6/d were continuously collected into waste medium at a density of 2-4 x 10(5) cells/mL, which resulted in stable operation at high perfusion rates, maintaining values of process parameters such as glucose/lactate concentration, pH, and dissolved oxygen concentration. Because the DFPS overcomes most drawbacks observed with conventional perfusion systems, it is preferable to be used as a key culture system to produce monoclonal antibody stably for a long culture period.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15903250     DOI: 10.1021/bp0497942

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  4 in total

Review 1.  The present state of the art in expression, production and characterization of monoclonal antibodies.

Authors:  Christopher L Gaughan
Journal:  Mol Divers       Date:  2015-08-25       Impact factor: 2.943

2.  Effects of supplementation of various medium components on chinese hamster ovary cell cultures producing recombinant antibody.

Authors:  Do Yun Kim; Joon Chul Lee; Ho Nam Chang; Duk Jae Oh
Journal:  Cytotechnology       Date:  2005-01       Impact factor: 2.058

3.  A protocol to transfer a fed-batch platform process into semi-perfusion mode: The benefit of automated small-scale bioreactors compared to shake flasks as scale-down model.

Authors:  Sabrina Janoschek; Markus Schulze; Gerben Zijlstra; Gerhard Greller; Jens Matuszczyk
Journal:  Biotechnol Prog       Date:  2018-12-19

Review 4.  Advances in recombinant antibody manufacturing.

Authors:  Renate Kunert; David Reinhart
Journal:  Appl Microbiol Biotechnol       Date:  2016-03-03       Impact factor: 4.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.